|
1
|
Louis DN: Molecular pathology of malignant
gliomas. Annu Rev Pathol. 1:97–117. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jiang T, Mao Y, Ma W, Mao Q, You Y, Yang
X, Jiang C, Kang C, Li X, Chen L, et al: CGCG clinical practice
guidelines for the management of adult diffuse gliomas. Cancer
Lett. 375:263–273. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li MY, Yang P, Liu YW, Zhang CB, Wang KY,
Wang YY, Yao K, Zhang W, Qiu XG, Li WB, et al: Low c-Met expression
levels are prognostic for and predict the benefits of temozolomide
chemotherapy in malignant gliomas. Sci Rep. 6:211412016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stupp R, Dietrich PY, Ostermann Kraljevic
S, Pica A, Maillard I, Maeder P, Meuli R, Janzer R, Pizzolato G,
Miralbell R, et al: Promising survival for patients with newly
diagnosed glioblastoma multiforme treated with concomitant
radiation plus temozolomide followed by adjuvant temozolomide. J
Clin Oncol. 20:1375–1382. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen J, Luan Y, Yu R, Zhang Z, Zhang J and
Wang W: Transient receptor potential (TRP) channels, promising
potential diagnostic and therapeutic tools for cancer. Biosci
Trends. 8:1–10. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wetsel WC: Sensing hot and cold with TRP
channels. Int J Hyperthermia. 27:388–398. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Park YR, Chun JN, So I, Kim HJ, Baek S,
Jeon JH and Shin SY: Data-driven analysis of TRP channels in
cancer: Linking variation in gene expression to clinical
significance. Cancer Genomics Proteomics. 13:83–90. 2016.PubMed/NCBI
|
|
8
|
Liu Z, Wu H, Wei Z, Wang X, Shen P, Wang
S, Wang A, Chen W and Lu Y: TRPM8: A potential target for cancer
treatment. J Cancer Res Clin Oncol. 142:1871–1881. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Alptekin M, Eroglu S, Tutar E, Sencan S,
Geyik MA, Ulasli M, Demiryurek AT and Camci C: Gene expressions of
TRP channels in glioblastoma multiforme and relation with survival.
Tumour Biol. 36:9209–9213. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang L and Barritt GJ: TRPM8 in prostate
cancer cells: A potential diagnostic and prognostic marker with a
secretory function? Endocr Relat Cancer. 13:27–38. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Burke RC, Bardet SM, Carr L, Romanenko S,
Arnaud-Cormos D, Leveque P and O'Connor RP: Nanosecond pulsed
electric fields depolarize transmembrane potential via
voltage-gated K+, Ca2+ and TRPM8 channels in
U87 glioblastoma cells. Biochim Biophys Acta Biomembr.
1859:2040–2050. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang M, Li Y, Chilukuri K, Brady OA,
Boulos MI, Kappes JC and Galileo DS: L1 stimulation of human glioma
cell motility correlates with FAK activation. J Neurooncol.
105:27–44. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Polivka J Jr, Polivka J, Holubec L,
Kubikova T, Priban V, Hes O, Pivovarcikova K and Treskova I:
Advances in experimental targeted therapy and immunotherapy for
patients with glioblastoma multiforme. Anticancer Res. 37:21–33.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Stoyanov GS and Dzhenkov DL: On the
concepts and history of glioblastoma Multiforme-Morphology,
genetics and epigenetics. Folia Med (Plovdiv). 60:48–66. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jhaveri N, Chen TC and Hofman FM: Tumor
vasculature and glioma stem cells: Contributions to glioma
progression. Cancer Lett. 380:545–551. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hardee ME and Zagzag D: Mechanisms of
glioma-associated neovascularization. Am J Pathol. 181:1126–1141.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. New Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sturm D, Bender S, Jones DT, Lichter P,
Grill J, Becher O, Hawkins C, Majewski J, Jones C, Costello JF, et
al: Paediatric and adult glioblastoma: Multiform (epi)genomic
culprits emerge. Nat Rev Cancer. 14:92–107. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Roderick HL and Cook SJ: Ca2+
signalling checkpoints in cancer: Remodelling Ca2+ for
cancer cell proliferation and survival. Nat Rev Cancer. 8:361–375.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun J, Mu H, Dai K and Yi L: Calreticulin:
A potential anti-cancer therapeutic target. Pharmazie. 72:503–510.
2017.PubMed/NCBI
|
|
21
|
Ohshima Y, Takata N, Suzuki-Karasaki M,
Yoshida Y, Tokuhashi Y and Suzuki-Karasaki Y: Disrupting
mitochondrial Ca2+ homeostasis causes tumor-selective
TRAIL sensitization through mitochondrial network abnormalities.
Int J Oncol. 51:1146–1158. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rizzuto R, Pinton P, Ferrari D, Chami M,
Szabadkai G, Magalhães PJ, Di Virgilio F and Pozzan T: Calcium and
apoptosis: Facts and hypotheses. Oncogene. 22:8619–8627. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fiorio Pla A and Gkika D: Emerging role of
TRP channels in cell migration: From tumor vascularization to
metastasis. Front Physiol. 4:3112013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hecquet CM, Zhang M, Mittal M, Vogel SM,
Di A, Gao X, Bonini MG and Malik AB: Cooperative interaction of trp
Melastatin channel transient receptor potential (TRPM2) with its
splice variant TRPM2 Short variant is essential for endothelial
cell apoptosis. Circ Res. 114:469–479. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Landsberg JW and Yuan JX: Calcium and TRP
channels in pulmonary vascular smooth muscle cell proliferation.
News Physiol Sci. 19:44–50. 2004.PubMed/NCBI
|
|
26
|
Hantute-Ghesquier A, Haustrate A,
Prevarskaya N and Lehen'kyi V: TRPM family channels in cancer.
Pharmaceuticals (Basel). 11(pii): E582018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gaunt HJ, Vasudev NS and Beech DJ:
Transient receptor potential canonical 4 and 5 proteins as targets
in cancer therapeutics. Eur Biophys J. 45:611–620. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wong KK, Banham AH, Yaacob NS and Nur
Husna SM: The oncogenic roles of TRPM ion channels in cancer. J
Cell Physiol. Feb 2–2019.doi: 10.1002/jcp.28168 (Epub ahead of
print).
|
|
29
|
Okamoto Y, Ohkubo T, Ikebe T and Yamazaki
J: Blockade of TRPM8 activity reduces the invasion potential of
oral squamous carcinoma cell lines. Int J Oncol. 40:1431–1440.
2012.PubMed/NCBI
|
|
30
|
Kijpornyongpan T, Sereemaspun A and
Chanchao C: Dose-dependent cytotoxic effects of menthol on human
malignant melanoma A-375 cells: Correlation with TRPM8 transcript
expression. Asian Pac J Cancer Prev. 15:1551–1556. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gkika D and Prevarskaya N: Molecular
mechanisms of TRP regulation in tumor growth and metastasis.
Biochim Biophys Acta. 1793:953–958. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sideris M, Emin EI, Abdullah Z, Hanrahan
J, Stefatou KM, Sevas V, Emin E, Hollingworth T, Odejinmi F,
Papagrigoriadis S, et al: The role of KRAS in endometrial cancer: A
mini-review. Anticancer Res. 39:533–539. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu F, Yang X, Geng M and Huang M:
Targeting ERK, an Achilles' Heel of the MAPK pathway, in cancer
therapy. Acta Pharm Sin B. 8:552–562. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sugden PH and Clerk A: Regulation of the
ERK subgroup of MAP kinase cascades through G protein-coupled
receptors. Cell Signal. 9:337–351. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Krueger JS, Keshamouni VG, Atanaskova N
and Reddy KB: Temporal and quantitative regulation of
mitogen-activated protein kinase (MAPK) modulates cell motility and
invasion. Oncogene. 20:4209–4218. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Samatar AA and Poulikakos PI: Targeting
RAS-ERK signalling in cancer: Promises and challenges. Nat Rev Drug
Discov. 13:928–942. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cobb MH, Hepler JE, Cheng M and Robbins D:
The mitogen-activated protein kinases, ERK1 and ERK2. Semin Cancer
Biol. 5:261–268. 1994.PubMed/NCBI
|
|
38
|
Chen WT, Hsu FT, Liu YC, Chen CH, Hsu LC
and Lin SS: Fluoxetine induces apoptosis through
extrinsic/intrinsic pathways and inhibits ERK/NF-κB-modulated
anti-apoptotic and invasive potential in hepatocellular carcinoma
cells in vitro. Int J Mol Sci. 20(pii): E7572019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
McIlwain DR, Berger T and Mak TW: Caspase
functions in cell death and disease. Cold Spring Harb Perspect
Biol. 5:a0086562013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wondergem R, Ecay TW, Mahieu F, Owsianik G
and Nilius B: HGF/SF and menthol increase human glioblastoma cell
calcium and migration. Biochem Biophys Res Commun. 372:210–215.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wondergem R and Bartley JW: Menthol
increases human glioblastoma intracellular Ca2+, BK
channel activity and cell migration. J Biomed Sci. 16:902009.
View Article : Google Scholar : PubMed/NCBI
|
